Sort
40,608 grants matching “prostate cancer”
A Real-Time Hyperspectral Laparoscopic Stereo Imaging System for Robot-Assisted Surgery
$589,457Baowei Fei · University Of Texas Dallas · R01 · FY2024 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER INTOBAGONIANS
$589,429University Of Pittsburgh At Pittsburgh · R01 · FY2001 · CA
Multi-cohort validation of machine learning radiogenomic models (ML-RGx) to predict late toxicity in prostate cancer
$589,425Sarah L. Kerns · Medical College Of Wisconsin · R01 · FY2024 · CA
EARLY DETECTION OF CANCER BY AFFINITY MASS SPECTROMETRY
$589,400Eastern Virginia Medical School · U01 · FY2001 · CA
PATHOGENESIS AND PROGRESSION OF PROSTATE CANCER
$589,372Pradip Roy-Burman · University Of Southern California · R01 · FY2011 · CA
Stromal Foxf2 suppresses prostate cancer progression
$589,337Li Xin · University Of Washington · R01 · FY2025 · CA
Molecular imaging of novel PARP inhibitor nanomedicine delivery
$589,327Henry F. Vanbrocklin · University Of California, San Francisco · R01 · FY2023 · CA
Prostate Cancer Radio-Pathomics for Differentiating Clinically Significant Disease
$589,239Peter S Laviolette · Medical College Of Wisconsin · R01 · FY2025 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$589,231Ira O Daar · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$589,231Ira Daar · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Therapeutic targeting of master regulators in non-canonical AR driven advanced lethal prostate cancers
$589,183Remi Adelaiye-Ogala · State University Of New York At Buffalo · R37 · FY2023 · CA
Genetic profiling in PCPT: prostate cancer risk, PSA levels, and chemoprevention
$589,179Jianfeng Xu · Wake Forest University Health Sciences · R01 · FY2011 · CA
The Maryland Regional Community Network Program To Elim*
$589,078Claudia Rose Baquet · University Of Maryland Baltimore · U01 · FY2008 · CA
Estimating Overdiagnosis in Cancer Screening Studies
$588,972Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
Glycosylation and Immune Evasion in Urologic Tumors
$588,870Sharon Pitteri · Stanford University · U01 · FY2022 · CA
Metastasis and biophysics of clusters of circulating tumor cells in the microcirculation
$588,815Mehmet Toner · Massachusetts General Hospital · U01 · FY2019 · CA
SPECIFIC PET IMAGING PROBES FOR EARLY DETECTION OF PROSTATE CANCER METASTASES
$588,750The University Of Texas Southwestern Medical Center · · FY2008 · Department of the Army
Project 1: Design Rules for Spherical Nucleic Acids that Target Cancer
$588,644Milan Mrksich · Northwestern University At Chicago · U54 · FY2015 · CA
MICRORNA BIOMARKERS TO GENERATE SENSITIVITY TO ABIRATERONE-RESISTANT PROSTATE CANCER
$588,463Cincinnati Univ Of · · FY2015 · Department of the Army
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
$588,460James A Stewart · University Of Wisconsin-Madison · U10 · FY2007 · CA
Posttranslational modifications of glucocorticoid receptor associated with drug-resistance in prostate cancer
$588,399Remi Adelaiye-Ogala · State University Of New York At Buffalo · R01 · FY2025 · CA
A Nested Case-Control Study of Prostate Carcinogenesis
$588,386Benjamin A. Rybicki · Henry Ford Health System · R01 · FY2008 · ES
Genetics and Molecular Mechanisms of Prostate Cancer
$588,377William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Development of Angiogenesis Inhibitors
$588,377William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
EXERCISE--AN INTERVENTION FOR FATIGUE IN CANCER PATIENTS
$588,293University Of California San Francisco · R01 · FY2000 · CA